ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19
October 13, 2021Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating acute respiratory infections, today announced that... -
Inhalon Collaborates with Celltrion, Inc. to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home
July 23, 2021Inhalon Biopharma today announced it is partnering with Celltrion, Inc. to develop IN-006, an inhaled form of regdanvimab, for treating patients with COVID-19.
Pharma Sources Insight January 2025
